Paper by Dr. Eric Latimer published in the April issue of "Clinical Schizophrenia & Related Psychoses"
Underprescribing of Clozapine and Unexplained Variation in Use Across Hospitals and Regions in the Canadian Province of Québec
Clinical guidelines recommend a trial of clozapine for schizophrenia patients who are refractory to other antipsychotics; its benefits for this population, including a reduction in suicide rates, have been documented in numerous studies. This paper uses Québec government administrative data (RAMQ and Med-Echo) to show tha
We are pleased to present
HENRY NASRALLAH, M.D.
Professor of Psychiatry & Neuroscience,
University of Cincinnati College of Medicine
The title of the presentation is:
THE EVOLVING LANDSCAPE OF NEUROBIOLOGY & PHARMACOTHERAPY IN SCHIZOPHRENIA